Jeffrey S. Hatfield, Chief Executive Officer at Vitae Pharmaceuticals, Inc (VTAE), sold 22,524 shares at $17.00 ($383K) on 2015-12-23, disclosed to the SEC on 2015-12-28.
Scheduled sale ($383k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.